BiotechTube
Home/Gero/Brian Kennedy, PhD
BK

Brian Kennedy, PhD

Independent Director, Board Member

Gero

Therapeutic Areas

AgingFibrosisNeurodegeneration

Gero Pipeline

DrugIndicationPhase
ProtoBind‑Diff Antibody CandidatesSystemic Aging / ResiliencePreclinical
Fibrosis Target ProgramFibrotic DiseasesPreclinical
Chugai Co‑Development AntibodyAge‑Related Immune DysfunctionPreclinical

Leadership Team at Gero

PF
Peter Fedichev, PhD
CEO, Co‑Founder
MK
Maxim Kholin
Chief Corporate Development Officer, Co‑Founder
AS
Aleksandr Sviridov
Chief Operating Officer
YM
Yuri Melnichek
Board Member
VG
Vadim Gladyshev, PhD
Scientific Advisor
View full Gero profile